Search Results - "Loghin, Monica E."

Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial by Rapp, Stephen R, Case, L Doug, Peiffer, Ann, Naughton, Michelle M, Chan, Michael D, Stieber, Volker W, Moore, Jr, Dennis F, Falchuk, Steven C, Piephoff, James V, Edenfield, William J, Giguere, Jeffrey K, Loghin, Monica E, Shaw, Edward G

“…Neurotoxic effects of brain irradiation include cognitive impairment in 50% to 90% of patients. Prior studies have suggested that donepezil, a neurotransmitter…”
Get full text

Phase 1 lead‐in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma by Maraka, Stefania, Groves, Morris D., Mammoser, Aaron G., Melguizo‐Gavilanes, Isaac, Conrad, Charles A., Tremont‐Lukats, Ivo W., Loghin, Monica E., O’Brien, Barbara J., Puduvalli, Vinay K., Sulman, Erik P., Hess, Kenneth R., Aldape, Kenneth D., Gilbert, Mark R., de Groot, John F., Alfred Yung, W.K., Penas‐Prado, Marta

“…Background Repurposed memantine, mefloquine, and metformin have putative anticancer activity. The objective of this phase 1 study was to determine the maximum…”
Get full text

Toxicity in the era of immune checkpoint inhibitor therapy by Keam, Synat, Turner, Naimah, Kugeratski, Fernanda G, Rico, Rene, Colunga-Minutti, Jocelynn, Poojary, Rayansh, Alekseev, Sayan, Patel, Anisha B, Li, Yuanteng Jeff, Sheshadri, Ajay, Loghin, Monica E, Woodman, Karin, Aaroe, Ashley E, Hamidi, Sarah, Iyer, Priyanka Chandrasekhar, Palaskas, Nicolas L, Wang, Yinghong, Nurieva, Roza

“…Immune checkpoint inhibitors (ICIs) reinvigorate anti-tumor immune responses by disrupting co-inhibitory immune checkpoint molecules such as programmed cell…”
Get full text

Chimeric antigen receptor T-cell therapy — assessment and management of toxicities by Neelapu, Sattva S., Tummala, Sudhakar, Kebriaei, Partow, Wierda, William, Gutierrez, Cristina, Locke, Frederick L., Komanduri, Krishna V., Lin, Yi, Jain, Nitin, Daver, Naval, Westin, Jason, Gulbis, Alison M., Loghin, Monica E., de Groot, John F., Adkins, Sherry, Davis, Suzanne E., Rezvani, Katayoun, Hwu, Patrick, Shpall, Elizabeth J.

“…Key Points Chimeric antigen receptor (CAR)-T-cell therapy is a promising approach for the treatment of refractory malignancies, but is associated with unique…”
Get full text

Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study by Kamiya-Matsuoka, Carlos, Paker, Asif M., Chi, Linda, Youssef, Ayda, Tummala, Sudhakar, Loghin, Monica E.

“…Posterior reversible encephalopathy syndrome (PRES) is a clinico-radiologic entity. Its management and outcome in the oncology population is limited because it…”
Get full text

Phase I Study of Temozolomide and Irinotecan for Recurrent Malignant Gliomas in Patients Receiving Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium Study by LOGHIN, Monica E, PRADOS, Michael D, CHANG, Susan M, CLOUGHESY, Timothy, DEANGELIS, Lisa M, ROBINS, Lan H, ALDAPE, Kenneth D, ALFRED YUNG, W. K, WEN, Patrick, JUNCK, Larry, LIEBERMAN, Frank, FINE, Howard, FINK, Karen L, METHA, Minesh, KUHN, John, LAMBORN, Kathleen

“…Purpose: To determine the maximum tolerated dose of irinotecan when administrated with temozolomide every 28 days, in patients with recurrent malignant glioma…”
Get full text

A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma by Weathers, Shiao-Pei, Han, Xiaosi, Liu, Diane D., Conrad, Charles A., Gilbert, Mark R., Loghin, Monica E., O’Brien, Barbara J., Penas-Prado, Marta, Puduvalli, Vinay K., Tremont-Lukats, Ivo, Colen, Rivka R., Yung, W. K. Alfred, de Groot, John F.

“…Antiangiogenic therapy can rapidly reduce vascular permeability and cerebral edema but high doses of bevacizumab may induce selective pressure to promote…”
Get full text

Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma by Penas-Prado, Marta, Hess, Kenneth R, Fisch, Michael J, Lagrone, Lore W, Groves, Morris D, Levin, Victor A, De Groot, John F, Puduvalli, Vinay K, Colman, Howard, Volas-Redd, Gena, Giglio, Pierre, Conrad, Charles A, Salacz, Michael E, Floyd, Justin D, Loghin, Monica E, Hsu, Sigmund H, Gonzalez, Javier, Chang, Eric L, Woo, Shiao Y, Mahajan, Anita, Aldape, Kenneth D, Yung, W K Alfred, Gilbert, Mark R

“…Chemoradiation, followed by adjuvant temozolomide, is the standard treatment for newly diagnosed glioblastoma. Adding other active agents may enhance treatment…”
Get full text

Posterior Reversible Encephalopathy Syndrome: A Neurologic Phenomenon in Cancer Patients by Le, Eileen M., Loghin, Monica E.

“…Posterior reversible encephalopathy syndrome is a well-recognized entity associated with a variety of benign and malignant conditions. This syndrome typically…”
Get full text

Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case-control study by Gregory, Timothy A, Knight, Stephanie R, Aaroe, Ashley E, Highsmith, Kaitlin N, Janatpour, Zachary C, O'Brien, Barbara J, Majd, Nazanin K, Loghin, Monica E, Patel, Chirag B, Weathers, Shiao-Pei, Puduvalli, Vinay K, Kamiya-Matsuoka, Carlos

“…We observed rapid tumor progression following COVID-19 infection among patients with glioblastoma and sought to systematically characterize their disease…”
Get full text

Prolonged survival in adult neurofibromatosis type I patients with recurrent high-grade gliomas treated with bevacizumab by Theeler, Brett J., Ellezam, Benjamin, Yust-Katz, Shlomit, Slopis, John M., Loghin, Monica E., de Groot, John F.

“…Astrocytic tumors, especially optic pathway pilocytic astrocytomas, are common in pediatric NF1 patients. High-grade gliomas (HGGs) appear to be rare in adult…”
Get full text

Spinal cord compression in cancer patients: Review of diagnosis and treatment by Penas-Prado, Marta, Loghin, Monica E.

“…Spinal cord compression (SCC) is a well-known complication in cancer patients, with an enormous potential impact on quality of life. In most cases, treatment…”
Get full text

Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy by Kim, Sang T., Chu, Yanshuo, Misoi, Mercy, Suarez-Almazor, Maria E., Tayar, Jean H., Lu, Huifang, Buni, Maryam, Kramer, Jordan, Rodriguez, Emma, Hussain, Zulekha, Neelapu, Sattva S., Wang, Jennifer, Shah, Amishi Y., Tannir, Nizar M., Campbell, Matthew T., Gibbons, Don L., Cascone, Tina, Lu, Charles, Blumenschein, George R., Altan, Mehmet, Lim, Bora, Valero, Vincente, Loghin, Monica E., Tu, Janet, Westin, Shannon N., Naing, Aung, Garcia-Manero, Guillermo, Abdel-Wahab, Noha, Tawbi, Hussein A., Hwu, Patrick, Oliva, Isabella C. Glitza, Davies, Michael A., Patel, Sapna P., Zou, Jun, Futreal, Andrew, Diab, Adi, Wang, Linghua, Nurieva, Roza

“…Immune checkpoint inhibitors are associated with immune-related adverse events (irAEs), including arthritis (arthritis-irAE). Management of arthritis-irAE is…”
Get full text

A Rare Case of Primary Angiitis of the Central Nervous System (PACNS) Associated with Metastatic Prostate Cancer (P3.155) by Hasan, Tasneem F., Maraka, Stefania, Leeds, Norman E., Loghin, Monica E.

“…Abstract only…”
Get full text

Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy by Kim, Sang T., Chu, Yanshuo, Misoi, Mercy, Suarez-Almazor, Maria E., Tayar, Jean H., Lu, Huifang, Buni, Maryam, Kramer, Jordan, Rodriguez, Emma, Hussain, Zulekha, Neelapu, Sattva S., Wang, Jennifer, Shah, Amishi Y., Tannir, Nizar M., Campbell, Matthew T., Gibbons, Don L., Cascone, Tina, Lu, Charles, Blumenschein, George R., Altan, Mehmet, Lim, Bora, Valero, Vincente, Loghin, Monica E., Tu, Janet, Westin, Shannon N., Naing, Aung, Garcia-Manero, Guillermo, Abdel-Wahab, Noha, Tawbi, Hussein A., Hwu, Patrick, Oliva, Isabella C. Glitza, Davies, Michael A., Patel, Sapna P., Zou, Jun, Futreal, Andrew, Diab, Adi, Wang, Linghua, Nurieva, Roza

Get full text

Phase I Study of Temozolomide and Irinotecan for Recurrent Malignant Gliomas in Patients Receiving Enzyme-Inducing Antiepileptic Drugs: A North American BrainTumor Consortium Study by Loghin, Monica E., Prados, Michael D., Wen, Patrick, Junck, Larry, Lieberman, Frank, Fine, Howard, Fink, Karen L., Metha, Minesh, Kuhn, John, Lamborn, Kathleen, Chang, Susan M., Cloughesy, Timothy, DeAngelis, Lisa M., Robins, Ian H., Aldape, Kenneth D., AlfredYung, W.K.

Get full text